Corona Prandi , B., P Rosim, M., Ogata Pedro, G., & Papadimitropoulos, M. (2023). Cost per number needed to treat and treatment cost of baricitinib versus adalimumab on rheumatoid arthritis treatment in the brazilian private healthcare system . JORNAL DE ASSISTÊNCIA FARMACÊUTICA E FARMACOECONOMIA, 4(s.1). https://doi.org/10.22563/2525-7323.2019.v4.s1.p.117